Edoxaban has similar efficacy to enoxaparin for thromboprophylaxis after THA
Safety and efficacy of edoxaban, an oral factor xa inhibitor, for thromboprophylaxis after total hip arthroplasty in Japan and TaiwanJ Arthroplasty. 2014 Dec;29(12):2439-46.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
264 patients scheduled for total hip arthroplasty were randomized to one of three groups: a group which received 15mg edoxaban daily, a group which received 30mg edoxaban daily, or a group which received 20mg of enoxaparin sodium twice daily. This was done to determine the safety, efficacy, and optimal dosage regimen of edoxaban as compared to enoxaparin in patients undergoing total hip arthroplas...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE